Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression (Q39686052)

From Wikidata

Jump to navigation Jump to search

scientific article published on 2 June 2010

Language	Label	Description	Also known as
English	Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression	scientific article published on 2 June 2010

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression (English)

1 reference

Europe PubMed Central

14 September 2017

author name string

Weiqiang Wang

1

1 reference

Europe PubMed Central

14 September 2017

Jingjing Zhao

2

1 reference

Europe PubMed Central

14 September 2017

Hongbin Wang

3

1 reference

Europe PubMed Central

14 September 2017

Yonggang Sun

4

1 reference

Europe PubMed Central

14 September 2017

Zhihong Peng

5

1 reference

Europe PubMed Central

14 September 2017

Gang Zhou

6

1 reference

Europe PubMed Central

14 September 2017

Lilin Fan

7

1 reference

Europe PubMed Central

14 September 2017

Xingwei Wang

8

1 reference

Europe PubMed Central

14 September 2017

Shiming Yang

9

1 reference

Europe PubMed Central

14 September 2017

Rongquan Wang

10

1 reference

Europe PubMed Central

14 September 2017

Dianchun Fang

11

1 reference

Europe PubMed Central

14 September 2017

language of work or name

0 references

publication date

2 June 2010

1 reference

Europe PubMed Central

14 September 2017

Experimental Cell Research

1 reference

Europe PubMed Central

14 September 2017

316

1 reference

Europe PubMed Central

14 September 2017

15

1 reference

Europe PubMed Central

14 September 2017

2456-2464

1 reference

Europe PubMed Central

14 September 2017

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

TRAIL/Apo-2L: mechanisms and clinical applications in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Intracellular mechanisms of TRAIL and its role in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

TRAIL: a molecule with multiple receptors and control mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Structural basis for inhibition of translation by the tumor suppressor Pdcd4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Signal transduction. Protein synthesis and oncogenesis meet again

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Increased expression of FLIP, an inhibitor of Fas‐mediated apoptosis, in stomach cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Upregulation of FLIP(S) by Akt, a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

The proteasome: a novel target for anticancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.027

7 January 2021

Identifiers

10.1016/J.YEXCR.2010.05.027

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39686052&oldid=1856362886"